Company Filing History:
Years Active: 2025
Title: Dobeen Hwang: Innovator in Antibody Drug Conjugates
Introduction
Dobeen Hwang is a notable inventor based in Palm Beach Gardens, Florida. He has made significant contributions to the field of biochemistry, particularly in the development of antibody compounds. His innovative work focuses on enhancing the efficacy of therapeutic applications through advanced antibody drug conjugates.
Latest Patents
Dobeen Hwang holds a patent for "Antibody compounds with reactive arginine and related antibody drug conjugates." This invention provides antibody compounds that incorporate a substitution of arginine for the reactive lysine residue (Lys99) in the hydrophobic cleft (38C2_Arg). The patent also details antibody drug conjugate compounds (ADCs) that feature cargo moieties site-specifically conjugated to the engineered arginine residue in the 38C2_Arg variant antibody. The therapeutic applications of these compounds are also highlighted in the patent.
Career Highlights
Dobeen Hwang is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore and develop innovative solutions in the field of antibody research. His contributions have been instrumental in advancing the understanding and application of antibody drug conjugates.
Collaborations
Dobeen has collaborated with esteemed colleagues such as Christoph Rader and Napon Nilchan. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Dobeen Hwang's work in antibody drug conjugates represents a significant advancement in therapeutic applications. His innovative approach and dedication to research continue to impact the field positively.